Purpose
Design
Participants
Methods
Main Outcome Measures
Results
Conclusions
Financial Disclosure(s)
Keywords
Abbreviations and Acronyms:
CDS (clinical decision support), EHR (electronic health record)Methods
- Nielsen J.
User-Centered Design Process Framework
Step 1: Specifying the Context of Use
Step 2: Specifying Design Requirements
Step 3: Creating Design Solutions
Step 4: Evaluating and Refining Designs
Results
Step 1: Specifying the Context of Use
Theme | Illustrative Statements |
---|---|
How clinicians currently make decisions regarding the timing of visual field testing | |
Timing adjustments are based on intuition | “Overall, I rely on my feeling more than on actual data.” “My decision about timing is pretty arbitrary.” |
Broad heuristics are used to adjust timing | “Using standard timings makes it easier for me to keep track of.” “For mild or moderate glaucoma, visual field every year.” |
Patient data and findings are used to adjust timing | “I do fields more frequently if I see progression.” “It’s different if they have a larger cup to disc.” |
Patient preferences are used to adjust timing | “Patient convenience influences my decision.” |
Clinicians with less glaucoma experience reported more difficulty determining the timing of visual field testing | |
Clinicians with less glaucoma experience have more difficulty | “I don’t see very much glaucoma, so it’s hard for me.” “It’s hard because my patients with glaucoma are mixed in with patients with many other conditions.” |
Clinicians desire help with determining the timing of visual field testing | |
Clinician desires compiled and easy to use data | “Gathering the data takes longer than evaluating it.” “It’s difficult to keep track of all of the patient data.” |
Clinician desires more certainty when determining timing | “I wish I could have more certainty about my recommendations.” “Sometimes, I’m not sure if the testing is necessary.” |
Clinician desires help communicating with patients regarding timing | “It’s hard to explain to patients why it’s important.” “It’s difficult for me to convince patients.” |
Clinician desires help keeping track of published literature regarding timing | “There is a lot of different published data, it’s difficult to incorporate into practice.” “The recommendations now are different than when I was in residency.” |
Step 2: Specifying Design Requirements
Theme | Fundamental Human Need Domain | Clinical Decision Support Design Requirement | Clinical Decision Support Design Feature |
---|---|---|---|
Timing adjustments are based on intuition | Creation | Design should allow for clinician autonomy | Sliding widgets to allow clinician inputs for assumptions |
Broad heuristics are used to adjust timing | Security | Design should incorporate currently used heuristics | Presentation of data commonly used to guide heuristics such as number of medications and central corneal thickness |
Patient data and findings are used to adjust timing | Freedom | Design should incorporate patient data and findings | Presentation of patient data and findings such as eye pressures and prior visual fields |
Patient preferences are used to adjust timing | Participation | Design should recognize patient preferences | Sliding widgets to allow patient input for assumptions |
Clinicians with less glaucoma experience have more difficulty | Security | Design should be accessible to non-experts who care for glaucoma | Option to click on different domains in the design for additional detail and explanation |
Clinician desires compiled and easy to use data | Idleness | Design should compile and present data in an efficient, easy to interpret format | Most pertinent data visible in a single initial user interface |
Clinician desires more certainty when determining timing | Protection | Design should improve certainty and communicate the level of certainty | Clear recommendations provided with statistical information to show level of certainty |
Clinician desires help communicating with patients regarding timing | Participation | Design should improve communication with patients | Display of data in graphical form to facilitate description to patients |
Clinician desires help keeping track of published literature regarding timing | Understanding | Design should incorporate published literature and inform users | Option to click on different domains for additional explanation and links to supporting published literature |
Step 3: Create Design Solutions
- (1)A glaucoma specialist who wants a recommendation for follow-up that is nuanced, so she is able to see the impact of alternative options.
- (2)A general ophthalmologist who wants a recommendation for follow-up that is presented efficiently, so he makes good decisions while seeing a lot of patients.
- (3)An optometrist who wants a recommendation for follow-up that she trusts, so she knows her patient is getting appropriate care.

Step 4: Evaluating and Refining Designs
Discussion
- Nielsen J.
References
- Optimizing Strategies for Clinical Decision Support: Summary of a Meeting Series.National Academy of Medicine, Bethesda, MD2017: 1
- A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.Int J Med Inform. 2017; 105: 22-30
- The effectiveness of computerised decision support on antibiotic use in hospitals: a systematic review.PLoS One. 2017; 12e0183062
- Use of computerized clinical decision support systems to prevent venous thromboembolism in surgical patients: a systematic review and meta-analysis.JAMA Surg. 2017; 152: 638-645
- Modeling the mind: how do we design effective decision-support?.J Biomed Inform. 2017; 71S: S1-S5
- Factors influencing implementation success of guideline-based clinical decision support systems: a systematic review and gaps analysis.Int J Med Inform. 2017; 98: 56-64
- TURF: toward a unified framework of EHR usability.J Biomed Inform. 2011; 44: 1056-1067
- Work system design for patient safety: the SEIPS model.Qual Saf Health Care. 2006; 15 Suppl 1: i50-i58
- User-centered design basics | Usability.gov.
- Primary open-angle glaucoma preferred practice pattern®.Ophthalmology. 2021; 128: P71-P150
- Special commentary: using clinical decision support systems to bring predictive models to the glaucoma clinic.Ophthalmol Glaucoma. 2021; 4: 5-9
- Interests and needs of eye care providers in clinical decision support for glaucoma.BMJ Open Ophthalmol. 2021; 6e000639
- The frequency of visual field testing in a US nationwide cohort of individuals with open-angle glaucoma.Ophthalmol Glaucoma. 2022; 5: 587-593
- Frequency of testing to detect visual field progression derived using a longitudinal cohort of glaucoma patients.Ophthalmology. 2017; 124: 786-792
- Longitudinal visual field variability and the ability to detect glaucoma progression in black and white individuals.Br J Ophthalmol. 2022; 106: 1115-1120
- Why you only need to test with 5 users. Nielsen Norman Group.https://www.nngroup.com/articles/why-you-only-need-to-test-with-5-users/Date: 2000Date accessed: May 2, 2020
- What can “thematic analysis” offer health and wellbeing researchers?.Int J Qual Stud Health Well-being. 2014; 9: 26152
- Qualitative Methods in Public Health. 2nd ed. Jossey-Bass A Wiley Brand, San Francisco, CA2016
- Human Scale Development: Conception, Application and Further Reflections.1991
- A categorization model of requirements based on Max-Neef’s model of human needs.Syst Eng. 2014; 17: 348-360
- Feeling and thinking: can theories of human motivation explain how EHR design impacts clinician burnout?.J Am Med Inform Assoc. 2021; 28: 1042-1046
- Think twice: a cognitive perspective of an antibiotic timeout intervention to improve antibiotic use.J Biomed Inform. 2017; 71S: S22-S31
- Computerized clinical decision support for prescribing: provision does not guarantee uptake.J Am Med Inform Assoc. 2010; 17: 25-33
- Time requirements for electronic health record use in an academic ophthalmology center.JAMA Ophthalmol. 2017; 135: 1250-1257
- Frequency of Visual Field Testing When Monitoring Patients Newly Diagnosed with Glaucoma.in: Mixed Methods and Modelling. NIHR Journals Library, Leeds, UK2014
Article info
Publication history
Footnotes
Disclosures:
All authors have completed and submitted the ICMJE disclosures form.
The authors made the following disclosures:
F.A.M.: Grants – Google, Inc, Carl-Zeiss Meditec, National Eye Institute, during the conduct of the study; Personal fees – Aerie Pharmaceuticals, Allergan, Novartis, Biogen, Galimedix, Annexon, Heidelberg Engineering, Stuart Therapeutics, IDx, Reichert. J.D.S.: Research grant – Abbvie, outside the submitted work. The other authors have no conflicts related to the proposed work to report.
Financial Support: This work was supported by National Institutes of Health (K23EY032577 to B.C.S., R01EY029885 to F.A.M., R01EY026641 to J.D.S.), an Unrestricted Grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah (B.C.S.) and the Department of Ophthalmology & Visual Sciences, University of Utah (J.D.S), and a Mentoring for the Advancement of Physician Scientists (M.A.P.S) grant from the American Glaucoma Society, San Francisco, California (B.C.S). The funding organizations had no role in the design or conduct of this research.
HUMAN SUBJECTS: This study was evaluated by the University of Utah Institutional Review Board and deemed exempt. The study adhered to the Declaration of Helsinki. This is a qualitative study using de-identified subject details.
No animal subjects were used in this study.
Author Contributions:
Conception and design: Stagg, Tullis, Asare, Stein, Medeiros, Weir, Borbolla, Hess, Kawamoto
Analysis and interpretation: Stagg, Tullis, Asare, Medeiros, Weir, Borbolla, Hess, Kawamoto
Data collection: Stagg, Tullis, Borbolla
Obtained funding: N/A
Overall responsibility: Stagg, Tullis, Asare, Stein, Medeiros, Weir, Borbolla, Hess, Kawamoto
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy